×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NYSE:NNVC

NanoViricides Stock Forecast, Price & News

$2.04
-0.07 (-3.32%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.04
$2.19
50-Day Range
$1.12
$2.60
52-Week Range
$1.04
$7.86
Volume
39,794 shs
Average Volume
33,050 shs
Market Capitalization
$23.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock Forecast (MarketRank)

Overall MarketRank

0.13 out of 5 stars

Medical Sector

1373rd out of 1,411 stocks

Pharmaceutical Preparations Industry

660th out of 672 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
NanoViricides logo

About NanoViricides (NYSE:NNVC)

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

NNVC Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Employees
17
Year Founded
N/A

Company Calendar

Last Earnings
5/17/2022
Today
6/26/2022
Fiscal Year End
6/30/2022

Profitability

Net Income
$-8.82 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.60 per share

Miscellaneous

Free Float
11,069,000
Market Cap
$23.56 million
Optionable
Optionable
Beta
1.03














NanoViricides Frequently Asked Questions

How has NanoViricides' stock price performed in 2022?

NanoViricides' stock was trading at $2.11 at the beginning of the year. Since then, NNVC stock has decreased by 3.3% and is now trading at $2.04.
View the best growth stocks for 2022 here
.

How were NanoViricides' earnings last quarter?

NanoViricides, Inc. (NYSE:NNVC) announced its earnings results on Tuesday, May, 17th. The company reported ($0.16) earnings per share for the quarter.
View NanoViricides' earnings history
.

Who are NanoViricides' key executives?

NanoViricides' management team includes the following people:
  • Dr. Anil R. Diwan Ph.D., Exec. Chairman, Pres, CEO & Sec. (Age 63, Pay $400k)
  • Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA, Chief Financial Officer (Age 63, Pay $129.6k)
  • Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 75)

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE) under the ticker symbol "NNVC."

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $2.04.

How much money does NanoViricides make?

NanoViricides (NYSE:NNVC) has a market capitalization of $23.56 million. The company earns $-8.82 million in net income (profit) each year or ($0.740010) on an earnings per share basis.

How many employees does NanoViricides have?

NanoViricides employs 17 workers across the globe.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, Shelton, Connecticut 06484-6153. The official website for NanoViricides is www.nanoviricides.com. The company can be reached via phone at (203) 937-6137, via email at [email protected], or via fax at 203-859-5095.

This page (NYSE:NNVC) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.